Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Tucci

Showing results (31-40 of 154) with videos related to

Pageof 16
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|July 6, 2026
The Prognostic Role of Interim [18F]FDG PET/CT in Diffuse Large B-Cell Lymphoma: An Updated Systematic Review and Meta-analysisDomenico Albano, Stephane Chauvie, Alessio Rizzo, et al.
Targeted Oncology|November 12, 2020
Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference ProductDietger Niederwieser, Caroline Hamm, Patrick Cobb, et al.
Cancer|May 16, 2007
Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphomaStefano Sacchi, Samantha Pozzi, Raffaella Marcheselli, et al.
Targeted Oncology|October 12, 2020
Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference ProductDietger Niederwieser, Caroline Hamm, Patrick Cobb, et al.
Blood Science (Baltimore, Md.)|March 12, 2026
Identification of two novel TP53 mutations in secondary acute myeloid leukemia following multiple myeloma: a case reportMaria Antonia De Francesco, Rossella Ribolla, Alessandra Sottini, et al.
Cancers|May 13, 2023
<sup>18</sup>F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor?Domenico Albano, Giorgio Treglia, Francesco Dondi, et al.
Annals of Hematology|April 26, 2020
Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in elderly HL: a two-center experience in 123 patientsDomenico Albano, Angelica Mazzoletti, Marianna Spallino, et al.
Leukemia & Lymphoma|July 25, 2020
Clinical and prognostic role of interim 18F-FDG PET/CT in elderly Hodgkin lymphoma: a dual-center experienceDomenico Albano, Angelica Mazzoletti, Vittorio Ruggero Zilioli, et al.
Italian Journal of Dermatology and Venereology|March 5, 2025
Cutaneous T-cell lymphomas: a real-life experience of anticipated use of mogamulizumab in ItalyMarco Ardigò, Leonardo Flenghi, Adalberto Ibatici, et al.
American Journal of Hematology|April 30, 2026
NGS-Driven Digital PCR for Personalized and Accurate Measurable Residual Disease Assessment in Acute Myeloid LeukemiaMirko Farina, Alessandro Leoni, Simona Bernardi, et al.
Pageof 16

Showing results (31-40 of 154) with videos related to

Sort By:
Pageof 16
Clinical Lymphoma, Myeloma & Leukemia|July 6, 2026
The Prognostic Role of Interim [18F]FDG PET/CT in Diffuse Large B-Cell Lymphoma: An Updated Systematic Review and Meta-analysisDomenico Albano, Stephane Chauvie, Alessio Rizzo, et al.
Targeted Oncology|November 12, 2020
Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference ProductDietger Niederwieser, Caroline Hamm, Patrick Cobb, et al.
Cancer|May 16, 2007
Rituximab in combination with fludarabine and cyclophosphamide in the treatment of patients with recurrent follicular lymphomaStefano Sacchi, Samantha Pozzi, Raffaella Marcheselli, et al.
Targeted Oncology|October 12, 2020
Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference ProductDietger Niederwieser, Caroline Hamm, Patrick Cobb, et al.
Blood Science (Baltimore, Md.)|March 12, 2026
Identification of two novel TP53 mutations in secondary acute myeloid leukemia following multiple myeloma: a case reportMaria Antonia De Francesco, Rossella Ribolla, Alessandra Sottini, et al.
Cancers|May 13, 2023
<sup>18</sup>F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor?Domenico Albano, Giorgio Treglia, Francesco Dondi, et al.
Annals of Hematology|April 26, 2020
Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in elderly HL: a two-center experience in 123 patientsDomenico Albano, Angelica Mazzoletti, Marianna Spallino, et al.
Leukemia & Lymphoma|July 25, 2020
Clinical and prognostic role of interim 18F-FDG PET/CT in elderly Hodgkin lymphoma: a dual-center experienceDomenico Albano, Angelica Mazzoletti, Vittorio Ruggero Zilioli, et al.
Italian Journal of Dermatology and Venereology|March 5, 2025
Cutaneous T-cell lymphomas: a real-life experience of anticipated use of mogamulizumab in ItalyMarco Ardigò, Leonardo Flenghi, Adalberto Ibatici, et al.
American Journal of Hematology|April 30, 2026
NGS-Driven Digital PCR for Personalized and Accurate Measurable Residual Disease Assessment in Acute Myeloid LeukemiaMirko Farina, Alessandro Leoni, Simona Bernardi, et al.
Pageof 16